Home Healthcare IT Genome Sequencing Market Size, Global Trends, Demand, Forecast to 2032

Genome Sequencing Market Size, Share & Trends Analysis Report By Product Type (Instruments, Reagents and Consumables, Software and Services), By Technology (Next-Generation Sequencing, Sanger Sequencing, Third-Generation Sequencing, Single-Molecule Real-Time Sequencing, Others), By Applications (Diagnostics, Drug Discovery, Precision Medicine, Environmental Genomics, Research, Others), By End-User (Hospitals and Clinics, Biotechnology and Pharmaceutical Companies, Contract Research Organizations (CROs), Government, Research Centers, Academic and Government Institutes, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI54813DR
Author : Debashree Bora

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Genome Sequencing Market Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Instruments
        1. By Value
      3. Reagents and Consumables
        1. By Value
      4. Software and Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing
        1. By Value
      3. Sanger Sequencing
        1. By Value
      4. Third-Generation Sequencing
        1. By Value
      5. Single-Molecule Real-Time Sequencing
        1. By Value
      6. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Diagnostics
        1. By Value
      3. Drug Discovery
        1. By Value
      4. Precision Medicine
        1. By Value
      5. Environmental Genomics
        1. By Value
      6. Research
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Biotechnology and Pharmaceutical Companies
        1. By Value
      4. Contract Research Organizations (CROs)
        1. By Value
      5. Government
        1. By Value
      6. Research Centers
        1. By Value
      7. Academic and Government Institutes
        1. By Value
      8. Others
        1. By Value
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Instruments
        1. By Value
      3. Reagents and Consumables
        1. By Value
      4. Software and Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing
        1. By Value
      3. Sanger Sequencing
        1. By Value
      4. Third-Generation Sequencing
        1. By Value
      5. Single-Molecule Real-Time Sequencing
        1. By Value
      6. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Diagnostics
        1. By Value
      3. Drug Discovery
        1. By Value
      4. Precision Medicine
        1. By Value
      5. Environmental Genomics
        1. By Value
      6. Research
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Biotechnology and Pharmaceutical Companies
        1. By Value
      4. Contract Research Organizations (CROs)
        1. By Value
      5. Government
        1. By Value
      6. Research Centers
        1. By Value
      7. Academic and Government Institutes
        1. By Value
      8. Others
        1. By Value
    6. U.S.
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Instruments
          1. By Value
        3. Reagents and Consumables
          1. By Value
        4. Software and Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing
          1. By Value
        3. Sanger Sequencing
          1. By Value
        4. Third-Generation Sequencing
          1. By Value
        5. Single-Molecule Real-Time Sequencing
          1. By Value
        6. Others
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Diagnostics
          1. By Value
        3. Drug Discovery
          1. By Value
        4. Precision Medicine
          1. By Value
        5. Environmental Genomics
          1. By Value
        6. Research
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Biotechnology and Pharmaceutical Companies
          1. By Value
        4. Contract Research Organizations (CROs)
          1. By Value
        5. Government
          1. By Value
        6. Research Centers
          1. By Value
        7. Academic and Government Institutes
          1. By Value
        8. Others
          1. By Value
    7. Canada
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Instruments
        1. By Value
      3. Reagents and Consumables
        1. By Value
      4. Software and Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing
        1. By Value
      3. Sanger Sequencing
        1. By Value
      4. Third-Generation Sequencing
        1. By Value
      5. Single-Molecule Real-Time Sequencing
        1. By Value
      6. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Diagnostics
        1. By Value
      3. Drug Discovery
        1. By Value
      4. Precision Medicine
        1. By Value
      5. Environmental Genomics
        1. By Value
      6. Research
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Biotechnology and Pharmaceutical Companies
        1. By Value
      4. Contract Research Organizations (CROs)
        1. By Value
      5. Government
        1. By Value
      6. Research Centers
        1. By Value
      7. Academic and Government Institutes
        1. By Value
      8. Others
        1. By Value
    6. U.K.
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Instruments
          1. By Value
        3. Reagents and Consumables
          1. By Value
        4. Software and Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing
          1. By Value
        3. Sanger Sequencing
          1. By Value
        4. Third-Generation Sequencing
          1. By Value
        5. Single-Molecule Real-Time Sequencing
          1. By Value
        6. Others
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Diagnostics
          1. By Value
        3. Drug Discovery
          1. By Value
        4. Precision Medicine
          1. By Value
        5. Environmental Genomics
          1. By Value
        6. Research
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Biotechnology and Pharmaceutical Companies
          1. By Value
        4. Contract Research Organizations (CROs)
          1. By Value
        5. Government
          1. By Value
        6. Research Centers
          1. By Value
        7. Academic and Government Institutes
          1. By Value
        8. Others
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Instruments
        1. By Value
      3. Reagents and Consumables
        1. By Value
      4. Software and Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing
        1. By Value
      3. Sanger Sequencing
        1. By Value
      4. Third-Generation Sequencing
        1. By Value
      5. Single-Molecule Real-Time Sequencing
        1. By Value
      6. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Diagnostics
        1. By Value
      3. Drug Discovery
        1. By Value
      4. Precision Medicine
        1. By Value
      5. Environmental Genomics
        1. By Value
      6. Research
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Biotechnology and Pharmaceutical Companies
        1. By Value
      4. Contract Research Organizations (CROs)
        1. By Value
      5. Government
        1. By Value
      6. Research Centers
        1. By Value
      7. Academic and Government Institutes
        1. By Value
      8. Others
        1. By Value
    6. China
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Instruments
          1. By Value
        3. Reagents and Consumables
          1. By Value
        4. Software and Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing
          1. By Value
        3. Sanger Sequencing
          1. By Value
        4. Third-Generation Sequencing
          1. By Value
        5. Single-Molecule Real-Time Sequencing
          1. By Value
        6. Others
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Diagnostics
          1. By Value
        3. Drug Discovery
          1. By Value
        4. Precision Medicine
          1. By Value
        5. Environmental Genomics
          1. By Value
        6. Research
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Biotechnology and Pharmaceutical Companies
          1. By Value
        4. Contract Research Organizations (CROs)
          1. By Value
        5. Government
          1. By Value
        6. Research Centers
          1. By Value
        7. Academic and Government Institutes
          1. By Value
        8. Others
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Instruments
        1. By Value
      3. Reagents and Consumables
        1. By Value
      4. Software and Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing
        1. By Value
      3. Sanger Sequencing
        1. By Value
      4. Third-Generation Sequencing
        1. By Value
      5. Single-Molecule Real-Time Sequencing
        1. By Value
      6. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Diagnostics
        1. By Value
      3. Drug Discovery
        1. By Value
      4. Precision Medicine
        1. By Value
      5. Environmental Genomics
        1. By Value
      6. Research
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Biotechnology and Pharmaceutical Companies
        1. By Value
      4. Contract Research Organizations (CROs)
        1. By Value
      5. Government
        1. By Value
      6. Research Centers
        1. By Value
      7. Academic and Government Institutes
        1. By Value
      8. Others
        1. By Value
    6. UAE
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Instruments
          1. By Value
        3. Reagents and Consumables
          1. By Value
        4. Software and Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing
          1. By Value
        3. Sanger Sequencing
          1. By Value
        4. Third-Generation Sequencing
          1. By Value
        5. Single-Molecule Real-Time Sequencing
          1. By Value
        6. Others
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Diagnostics
          1. By Value
        3. Drug Discovery
          1. By Value
        4. Precision Medicine
          1. By Value
        5. Environmental Genomics
          1. By Value
        6. Research
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Biotechnology and Pharmaceutical Companies
          1. By Value
        4. Contract Research Organizations (CROs)
          1. By Value
        5. Government
          1. By Value
        6. Research Centers
          1. By Value
        7. Academic and Government Institutes
          1. By Value
        8. Others
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Instruments
        1. By Value
      3. Reagents and Consumables
        1. By Value
      4. Software and Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing
        1. By Value
      3. Sanger Sequencing
        1. By Value
      4. Third-Generation Sequencing
        1. By Value
      5. Single-Molecule Real-Time Sequencing
        1. By Value
      6. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Diagnostics
        1. By Value
      3. Drug Discovery
        1. By Value
      4. Precision Medicine
        1. By Value
      5. Environmental Genomics
        1. By Value
      6. Research
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Biotechnology and Pharmaceutical Companies
        1. By Value
      4. Contract Research Organizations (CROs)
        1. By Value
      5. Government
        1. By Value
      6. Research Centers
        1. By Value
      7. Academic and Government Institutes
        1. By Value
      8. Others
        1. By Value
    6. Brazil
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Instruments
          1. By Value
        3. Reagents and Consumables
          1. By Value
        4. Software and Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing
          1. By Value
        3. Sanger Sequencing
          1. By Value
        4. Third-Generation Sequencing
          1. By Value
        5. Single-Molecule Real-Time Sequencing
          1. By Value
        6. Others
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Diagnostics
          1. By Value
        3. Drug Discovery
          1. By Value
        4. Precision Medicine
          1. By Value
        5. Environmental Genomics
          1. By Value
        6. Research
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Biotechnology and Pharmaceutical Companies
          1. By Value
        4. Contract Research Organizations (CROs)
          1. By Value
        5. Government
          1. By Value
        6. Research Centers
          1. By Value
        7. Academic and Government Institutes
          1. By Value
        8. Others
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Genome Sequencing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Illumina
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Thermo Fischer Scientific
    3. Oxford Nanopore technology
    4. Pacific Biosciences
    5. F. Hoffmann-La Roche
    6. PerkinElmer
    7. Siemens Healthineers
    8. Macrogen
    9. Myriad Genetics
    10. Cytiva
    11. BioMatter
    12. 10x Genomics
    13. BGI
    14. MGI Tech
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Genome Editing Market Size The global genome editing market size was valued at USD 6.20 billion in 2022 and is projected to reach USD 25.26 billion by 2031, with a CAGR of 16.9 % during the forecast period 2023–2031. 
Buy Now
Global Report
The global long read sequencing market size was valued at USD 825.80million in 2019 and is expected to grow at 24.29% CAGR during the forecast period. Long-read sequencing is a next-generation sequencing technique with high throughput. It is us
Buy Now
Global Report
The global metagenomic sequencing market size was worth USD 1,355 million in 2021 and is expected to reach USD 5,785 million by 2030, growing at a CAGR of 17.5% during the forecast period (2022–2030).  Metagenomics is a biological approac
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :